SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-210092
Filing Date
2020-08-05
Accepted
2020-08-05 09:16:19
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d34906d424b5.htm 424B5 324635
2 GRAPHIC g34906g31n48.jpg GRAPHIC 43976
3 GRAPHIC g34906g32b94.jpg GRAPHIC 47689
4 GRAPHIC g34906g33q91.jpg GRAPHIC 41162
5 GRAPHIC g34906g46e49.jpg GRAPHIC 40510
  Complete submission text file 0001193125-20-210092.txt   553145
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-228581 | Film No.: 201075899
SIC: 3826 Laboratory Analytical Instruments